These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


139 related items for PubMed ID: 9148400

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Predictors of relapse rate in MS clinical trials.
    Held U, Heigenhauser L, Shang C, Kappos L, Polman C, Sylvia Lawry Centre for MS Research.
    Neurology; 2005 Dec 13; 65(11):1769-73. PubMed ID: 16344520
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Age at disability milestones in multiple sclerosis.
    Confavreux C, Vukusic S.
    Brain; 2006 Mar 13; 129(Pt 3):595-605. PubMed ID: 16415309
    [Abstract] [Full Text] [Related]

  • 8. Infratentorial lesions predict long-term disability in patients with initial findings suggestive of multiple sclerosis.
    Minneboo A, Barkhof F, Polman CH, Uitdehaag BM, Knol DL, Castelijns JA.
    Arch Neurol; 2004 Feb 13; 61(2):217-21. PubMed ID: 14967769
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Multiple sclerosis: relapses and timing of remissions.
    Iuliano G, Napoletano R, Esposito A.
    Eur Neurol; 2008 Feb 13; 59(1-2):44-8. PubMed ID: 17917457
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. The effect of interferon-beta1a on relapses and progression of disability in patients with clinically isolated syndromes (CIS) suggestive of multiple sclerosis.
    Motamed MR, Najimi N, Fereshtehnejad SM.
    Clin Neurol Neurosurg; 2007 May 13; 109(4):344-9. PubMed ID: 17300863
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 7.